Dr. Bum Suck Lee, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 400 Fort Hill Ave, Canandaigua, NY 14424 Phone: 585-393-7276 |
Ms. Diane D Lu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 699 S Main St, Canandaigua, NY 14424 Phone: 585-275-2838 Fax: 585-396-9713 |
Jillian Joy Parshall, NP Urology Medicare: Accepting Medicare Assignments Practice Location: 229 Parrish St Ste 200, Canandaigua, NY 14424 Phone: 585-275-2838 |
Thomas Louis Osinski, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 699 S Main St Ste 6, Canandaigua, NY 14424 Phone: 585-275-2838 |
Guan Wu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 699 S Main St Ste 6, Canandaigua, NY 14424 Phone: 585-275-2838 Fax: 585-273-1068 |
Dr. Jared Wachterman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 699 S Main St Ste 6, Canandaigua, NY 14424 Phone: 585-275-2838 |
Shlomi Tapiero, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 699 S Main St, Canandaigua, NY 14424 Phone: 585-275-2838 |
News Archive
For two years, Saint Anthony Hospital here has celebrated its top-rated "A" grade from the national Leapfrog Group that evaluates hospital safety records. But this fall, when executives opened a preview of their score, they got an unwelcome surprise: a "C."
Nearly 28 percent of California's children have untreated tooth decay, according to the 2006 California Smile Survey, Mommy It Hurts to Chew. Families with low incomes and people with complex medical conditions face considerable barriers to obtaining dental care and have significantly worse oral health than other segments of the population.
Findings from a new study released today estimate that measurable medical errors cost the U.S. economy $19.5 billion in 2008. Commissioned by the Society of Actuaries (SOA) and completed by consultants with Milliman, Inc., the report used claims data to provide an actuarially sound measurement of costs for avoidable medical injuries. Of the approximately $80 billion in costs associated with medical injuries, around 25 percent were the result of avoidable medical errors.
Eurand has announced that Eurand Pharmaceuticals Ltd. initiated the rolling submission of its new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for Zentase for the treatment of Exocrine Pancreatic Insufficiency (EPI). Zentase (formerly EUR-1008), the company's lead product candidate, has been granted fast-track designation by the FDA.
› Verified 9 days ago